HI TECH PHARMACAL CO INC 4

Accession 0001566028-13-000024

CIK 0000887497operating

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 2:02 PM ET

Size

25.9 KB

Accession

0001566028-13-000024

Form 4

Period: 2013-10-01

Director

Transactions

Exercise/Conversion
Common Stock
2013-10-01$19.59/sh+2,500$48,975→ 17,968 total
Exercise/Conversion
Common Stock
2013-10-01$22.25/sh+5,000$111,250→ 22,968 total
Exercise/Conversion
Common Stock
2013-10-01$5.83/sh+3,093$18,032→ 15,468 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-10-01−3,093→ 0 total
Exercise: $5.83From: 2009-11-13Exp: 2018-11-13→ Common Stock (3,093 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-10-01−2,500→ 7,500 total
Exercise: $32.59From: 2013-07-16Exp: 2022-07-16→ Common Stock (2,500 underlying)
Exercise/Conversion
Common Stock
2013-10-01$24.95/sh+12,375$308,756→ 12,375 total
Exercise/Conversion
Common Stock
2013-10-01$32.59/sh+2,500$81,475→ 25,468 total
Sale
Common Stock
2013-10-01$43.15/sh−15,368$663,129→ 10,100 total
Sale
Common Stock
2013-10-02$43.14/sh−10,100$435,714→ 0 total
Exercise/Conversion
Stock Option (Right to Buy)
2013-10-01−12,375→ 0 total
Exercise: $24.95From: 2006-11-08Exp: 2015-11-08→ Common Stock (12,375 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-10-01−2,500→ 2,500 total
Exercise: $19.59From: 2010-11-12Exp: 2019-11-12→ Common Stock (2,500 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2013-10-01−5,000→ 5,000 total
Exercise: $22.25From: 2011-11-10Exp: 2020-11-10→ Common Stock (5,000 underlying)

Footnotes (5)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.12 to $43.21, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1) and (2) of this Form 4.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.10 to $43.20, inclusive.
[F3]Option granted under Hi-Tech Pharmacal Co., Inc.'s 1994 Directors Stock Option Plan, which is a Rule 16b-3 Plan.
[F4]The option became (or becomes) exercisable in four equal annual installments beginning on the first anniversary of the grant date.
[F5]Other than the options to acquire an aggregate of 15,000 shares reflected on this form as still held by the filer, the filer is also the holder of an additional option to acquire 10,000 shares of Hi-Tech Common Stock (for total options to acquire an aggegate of 25,000 shares currently held by Mr. Simpson).

Documents

1 file

HI TECH PHARMACAL CO INC

CIK 0000887497

Entity typeoperating

IncorporatedNY